Publicaciones en las que colabora con José Bruno Celso Fariña Espinosa (24)

2024

  1. Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries

    PLoS ONE, Vol. 19, Núm. 5 May

  2. Revolutionizing Three-Dimensional Printing: Enhancing Quality Assurance and Point-of-Care Integration through Instrumentation

    Pharmaceutics, Vol. 16, Núm. 3

2023

  1. A pharmaceutical monitoring system to assess the quality of antituberculosis drug products used in Mauritania

    PLoS ONE, Vol. 18, Núm. 3 March

  2. Characterization and Validation of a New 3D Printing Ink for Reducing Therapeutic Gap in Pediatrics through Individualized Medicines

    Pharmaceutics, Vol. 15, Núm. 6

2022

  1. Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis

    Molecules, Vol. 27, Núm. 20

2021

  1. Desarrollo y control de calidad de dos formulaciones de budesonida viscosa para administración oral en pediatría

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 193-194

  2. Desarrollo y control de calidad de dos formulaciones de budesonida viscosa para administración oral en pediatría

    XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica

  3. Diseño y desarrollo de un sistema automatizado para el control global de la impresión 3D de medicamentos pediátricos

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 18-20

  4. Diseño y desarrollo de un sistema automatizado para el control global de la impresión 3D de medicamentos pediátricos

    Congreso de la sociedad española de farmacia industrial y galénica (15º.2021.Sevilla)

  5. Individualized orodispersible pediatric dosage forms obtained by molding and semi-solid extrusion by 3D printing: A comparative study for hydrochlorothiazide

    Journal of Drug Delivery Science and Technology, Vol. 66

  6. Monitoring system for substandard detection of antituberculosis drugs used in the Mauritanian National Health System

    XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica

  7. Monitoring system for substandard detection of antituberculosis drugs used in the Mauritanian National Health System

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 90-92

  8. Pharmaceutical equivalence and stability study of levofloxacin tablets commercialized in Europe and Africa

    XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica

  9. Pharmaceutical equivalence and stability study of levofloxacin tablets commercialized in Europe and Africa

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 33-35

  10. Supercritical CO2 technology for one-pot foaming and sterilization of polymeric scaffolds for bone regeneration

    International Journal of Pharmaceutics, Vol. 605, pp. 120801

2020

  1. Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics

    Drug Development and Industrial Pharmacy, Vol. 46, Núm. 2, pp. 309-317

  2. Stability study of isoniazid and rifampicin oral solutions using hydroxypropyl-Β-cyclodextrin to treat tuberculosis in paediatrics

    Pharmaceutics, Vol. 12, Núm. 2

2019

  1. A High-Demanding Strategy to Ensure the Highest Quality Standards of Oral Liquid Individualized Medicines for Pediatric Use

    AAPS PharmSciTech, Vol. 20, Núm. 5

2018

  1. Development of a novel physico-chemically and microbiologically stable oral solution of flecainide for pediatrics

    Pharmaceutical Development and Technology, Vol. 23, Núm. 10, pp. 978-985

  2. Dilute solutions of parahydroxybenzoates (parabens) as possible alternative for antimicrobial preservation in oral formulations for pediatrics

    International Journal of Pharmaceutics, Vol. 536, Núm. 2, pp. 500-501